[Systemic lupus erythematosus].
Funauchi
Masanori
M
Department of Hematology, Nephrology and Rheumatology, Kinki University School of Medicine.
Yamagata
Toshiaki
T
D000974:Antibodies, Antinuclear / Q000302:isolation & purification; D000925:Anticoagulants; D000936:Antigen-Antibody Complex / Q000302:isolation & purification; D001323:Autoantibodies / Q000302:isolation & purification; D006801:Humans; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D008775:Methylprednisolone / Q000008:administration & dosage; D010949:Plasma; D010956:Plasmapheresis / Q000009:adverse effects / Q000379:methods*
D000974:Antibodies, Antinuclear; D000925:Anticoagulants; D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D008775:Methylprednisolone